These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 12947333)

  • 21. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
    Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J
    Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
    Zhang HM; Zhang LW; Liu WC; Cheng J; Si XM; Ren J
    Cytotherapy; 2006; 8(6):580-8. PubMed ID: 17148035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses.
    Smith SG; Patel PM; Porte J; Selby PJ; Jackson AM
    Clin Cancer Res; 2001 Dec; 7(12):4253-61. PubMed ID: 11751527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J; Jacobs P; Doffek K; Sugg SL
    J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.
    Calderhead DM; DeBenedette MA; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
    J Immunother; 2008 Oct; 31(8):731-41. PubMed ID: 18779746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
    Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR
    Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro.
    Vujanovic L; Ranieri E; Gambotto A; Olson WC; Kirkwood JM; Storkus WJ
    Cancer Gene Ther; 2006 Aug; 13(8):798-805. PubMed ID: 16645618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors.
    Philip R; Brunette E; Ashton J; Alters S; Gadea J; Sorich M; Yau J; O'Donoghue G; Lebkowski J; Okarma T; Philip M
    Cancer Gene Ther; 1998; 5(4):236-46. PubMed ID: 9694075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.
    Miconnet I; Pantaleo G
    Vaccine; 2008 Jul; 26(32):4006-14. PubMed ID: 18562050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.
    Hao X; Shao Y; Ren X; Liu H; Xu Q; Li H; Zhang P; An X; Ren B
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):507-15. PubMed ID: 12242516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
    Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
    Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.
    Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B
    Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
    Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS
    Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells.
    Hoffmann TK; Meidenbauer N; Müller-Berghaus J; Storkus WJ; Whiteside TL
    J Immunother; 2001; 24(2):162-71. PubMed ID: 11265774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells.
    Galetto A; Contarini M; Sapino A; Cassoni P; Consalvo E; Forno S; Pezzi C; Barnaba V; Mussa A; Matera L
    J Surg Res; 2001 Sep; 100(1):32-8. PubMed ID: 11516202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.